Clinical Trial Update: A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating palbociclib in combination with bazedoxifene for hormone receptor–positive breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bazedoxifene (bazedoxifene)
• Palbociclib (palbociclib)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer Stage IV, Unresectable Locally Advanced Invasive Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-07-01